LenzW. Kindliche missbildungen nach medikamment — einnahme während der graviditat?Deut Med Wochr1961; 86: 2555
2.
SweetDLKinzicJ. Consequences of radiotherapy and antineoplastic therapy for the fetus. J Reprod Med1976; 17: 241–246
3.
BarberHRK. Fetal and neonatal effects of cytotoxic agents. Obstet Gynecol1981; 58: 41S–47S
4.
SmithellsRW. Environmental teratogens of man. Br Med Bull1976; 32: 27–33
5.
JickSSTerrisBZ. Anticonvulsants and congenital malformations. Pharmacotherapy1997; 17: 561–564
6.
BialeYLewenthalH. Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs. Eur J Obstet Gynecol Reprod Biol1984; 18: 211–216
7.
NakameYOkumaTTakahashiR. Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs. A report of a collaborative study in Japan. Epilepsia1980; 21: 663–680
8.
LindoutDHöppenerRJEAMeinardiH. Teragenicity of antiepileptic drug combinations with special reference on expoxidation (of carbamazepine). Epilepsia1984; 25: 77–83
9.
HawkinsDF. Prescribing in pregnancy. Epilepsy: protecting the mother and her baby. Prescriber1996; 7 (10): 19–24
10.
LanderCMEadieMJ. Plasma antiepileptic drug concentrations during pregnancy. Epilepsia1991; 32: 257–266
11.
MountainKRHirshJCallusAS. Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet1970; I: 265–268
12.
MillerEHareJWClohertyJP. Elevated maternal hemoglobin Alc in early pregnancy and major congenital abnormalities in infants of diabetic mothers. N Engl J Med1981; 304: 1331–1334
13.
ChahalPHawkinsDF. Diabetes and Pregnancy. London: Butterworths1989: 113–114
14.
HallJGPauliRMWilsonKM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med1980; 68: 122–140
15.
LaoTTDe SwietMLetskyEWaltersBNJ. Prophylaxis of thromboembolism in pregnancy: an alternative. Br J Obstet Gynaecol1985; 92: 202–206
16.
OakleyC. Artificial heart valves. In: OakleyC (Ed). Heart Disease in Pregnancy. London: B M J Publications Group1997: 135–146
17.
Department of Health. Report on confidential enquiries into maternal deaths in the United Kingdom. 1991–1993. London: Her Majesty's Stationery Office1996: 58–59
18.
ShennanAHDe SwietM. Thromboembolism in obstetrics. Clinical Risk1997; 3: 109–113
19.
HawkinsDF. Assessment of teratogenicity. J Psychopharmacol1992; 6: 225–229
20.
ShepardTH. Catalogue of teratogenic agents, 8th edn.Baltimore and London: John Hopkins University Press. 1995
21.
RubinPCButtersLClarkDL. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet1983; i: 431–434
22.
MageeCALurieIKuehlKFerenczCLoffredoC. Baltimore-Washington Infant Study Group. Looping anomalies of the heart and great vessels; associated risk factors. Teratology1994; 49: 372
23.
LedwardRSHawkinsDFSternL. Preconception counselling. In: Drug Treatment in Obstetrics, 2nd edn.London: Chapman and Hall Medical1991: 1–15
24.
De SwietM. Medical Disorders in Obstetric Practice. 3rd edn.Oxford: Blackwell Science, 1995
25.
GleicherN. Principles of Medical Therapy in Pregnancy. 2nd edn.Norwalk, Connecticut: Appleton and Lange, 1992